More on ARRY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-52.0% Growth)
- Ratings (5.8 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/11/26)
- M&A (12/31/19 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ARRY Cash Flow Statement

Click line-items for a historical chart and %
Net loss -28.61M
Depreciation and amortization expense 475K
Non-cash interest expense
Share-based compensation expense 1.91M
Gains (losses) on auction rate securities
Prepaid expenses and other current assets 2.52M
Accounts payable and other accrued expenses -3.35M
Accrued outsourcing costs 6.41M
Accrued compensation and benefits
Deferred rent 284K
Deferred revenue -4.68M
Other long-term liabilities 23K
Net cash provided by (used in) operating activities -14.61M
Purchases of property and equipment -1.05M
Purchases of marketable securities
Proceeds from sales and maturities of marketable securities
Net cash provided by investing activities 1.47M
Proceeds from exercise of stock options and shares issued under the Employee Stock Purchase Plan
Proceeds from the issuance of common stock for cash 12.57M
Payment of offering costs
Net cash provided by financing activities 22.38M
Net increase (decrease) in cash and cash equivalents 9.24M
Cash and cash equivalents as of beginning of period 56.6M
Cash and cash equivalents as of end of period 65.84M
Cash paid for interest 130K